Related Experiment Videos
Platelet-derived growth factor in human brain tumors
M Kirsch1, J C Wilson, P Black
1Neurosurgical Laboratories, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Journal of Neuro-Oncology
|January 24, 1998
Summary
The PDGF family plays a role in neural development and brain tumor pathogenesis. Therapies targeting PDGF receptor antagonists or dominant negative mutants show potential for treating astrocytoma, meningioma, and pituitary adenoma.
Area of Science:
- Neuroscience
- Oncology
- Molecular Biology
Background:
- The Platelet-Derived Growth Factor (PDGF) family and its signaling pathways are crucial in cellular communication.
- Dysregulation of PDGF signaling is implicated in various human diseases, including cancer.
Purpose of the Study:
- To review the PDGF ligand and receptor systems and their signaling mechanisms.
- To elucidate the role of the PDGF family in the pathogenesis of specific brain tumors: astrocytoma, meningioma, and pituitary adenoma.
- To discuss potential therapeutic strategies targeting the PDGF pathway.
Main Methods:
- Literature review of PDGF family signaling in neural development.
- Analysis of the involvement of PDGF in the pathogenesis of astrocytoma, meningioma, and pituitary adenoma.
- Exploration of therapeutic approaches using receptor antagonists and dominant negative mutants.
Main Results:
- The PDGF system is integral to normal neural development.
- The PDGF family is implicated in the development of astrocytoma, meningioma, and pituitary adenoma.
- Receptor antagonists and dominant negative mutants represent promising therapeutic avenues.
Conclusions:
- The PDGF signaling pathway is a significant factor in brain tumor formation.
- Targeting PDGF receptors offers a potential strategy for novel brain tumor therapies.